Education
About Us
Working with TipRanks
Follow Us
Evolent Health Inc. (EVH)
:EVH
Total Valuation
Evolent Health has a market cap or net worth of $1.03B. The enterprise value is $1.67B.
Market Cap$1.03B
Enterprise Value$1.67B
Share Statistics
Evolent Health has 117,399,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding117,399,810
Owned by Insiders1.94%
Owned by Institutions41.55%
Financial Efficiency
Evolent Health’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.95%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-1.95%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee567.72K
Profits Per Employee-13.69K
Employee Count4,500
Asset Turnover1.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evolent Health is -20.94. Evolent Health’s PEG ratio is -6.50.
PE Ratio-20.94
PS Ratio0.00
PB Ratio1.04
Price to Fair Value1.29
Price to FCF-173.38
Price to Operating Cash Flow55.48
PEG Ratio-6.50
Income Statement
In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.
Revenue2.55B
Gross Profit367.35M
Operating Income-40.48M
Pretax Income-63.04M
Net Income-61.62M
EBITDA84.85M
Earnings Per Share (EPS)-0.81
Cash Flow
In the last 12 months, operating cash flow was 18.77M and capital expenditures -24.89M, giving a free cash flow of -6.13M billion.
Operating Cash Flow18.77M
Free Cash Flow-6.13M
Free Cash Flow per Share-0.05
Dividends & Yields
Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.02
52-Week Price Change-65.62%
50-Day Moving Average9.54
200-Day Moving Average16.11
Relative Strength Index (RSI)33.70
Average Volume (3m)2.43M
Important Dates
Evolent Health upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date―
Financial Position
Evolent Health as a current ratio of 0.85, with Debt / Equity ratio of 71.28%
Current Ratio0.85
Quick Ratio0.85
Debt to Market Cap0.53
Net Debt to EBITDA7.18
Interest Coverage Ratio-1.64
Taxes
In the past 12 months, Evolent Health has paid -1.41M in taxes.
Income Tax-1.41M
Effective Tax Rate0.02
Enterprise Valuation
Evolent Health EV to EBITDA ratio is 22.39, with an EV/FCF ratio of -309.99.
EV to Sales0.74
EV to EBITDA22.39
EV to Free Cash Flow-309.99
EV to Operating Cash Flow101.23
Balance Sheet
Evolent Health has $163.50M in cash and marketable securities with $713.67M in debt, giving a net cash position of $550.17M billion.
Cash & Marketable Securities$163.50M
Total Debt$713.67M
Net Cash$550.17M
Net Cash Per Share$4.69
Tangible Book Value Per Share-$7.12
Margins
Gross margin is 12.04%, with operating margin of -1.58%, and net profit margin of -2.41%.
Gross Margin12.04%
Operating Margin-1.58%
Pretax Margin-2.47%
Net Profit Margin-2.41%
EBITDA Margin3.32%
EBIT Margin-1.50%
Analyst Forecast
The average price target for Evolent Health is $15.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.00
Price Target Upside87.50% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast10.24%
EPS Growth Forecast2.63%